GO:1901342 regulation of vasculature development

Regulation of vasculature development (GO:1901342) is a biological process that encompasses any molecular or cellular event that modulates the frequency, rate, or extent of the formation and remodeling of blood vessels. This process is fundamental to embryonic organogenesis, tissue repair, and the maintenance of physiological homeostasis, and its disruption underlies numerous pathological conditions including cancer, retinopathies, and developmental syndromes [1, 3, 4]. The term is defined in QuickGO as any process that modulates the frequency, rate or extent of vasculature development, with the synonym regulation of vascular system development. Researchers study this process to understand how signaling pathways, transcription factors, and environmental cues converge to shape vascular networks in health and disease [1, 2, 6]. Vasculature development itself involves the de novo formation of blood vessels (vasculogenesis) and the sprouting of new vessels from existing ones (angiogenesis), as well as remodeling and maturation steps. Regulation of these events occurs at multiple levels: transcriptional control of endothelial cell fate, paracrine signaling from surrounding tissues, and systemic metabolic cues [1, 4, 7]. For example, Notch signaling acts as a key angiocrine regulator in tumor development, influencing both endothelial and perivascular cells. In the lung, reciprocal signaling between the developing epithelium and vascular system is essential for proper organogenesis and regeneration. Because vasculature development is a highly coordinated process, its dysregulation can lead to severe consequences. Abnormal vascular development in the hindbrain of zebrafish with reduced rps20 expression highlights the sensitivity of this process to ribosomal stress. Similarly, reduced expression of pantothenate kinase 2 (pank2) in zebrafish embryos causes abnormal vasculature development, linking metabolic dysfunction to vascular phenotypes. These examples illustrate the broad relevance of GO:1901342 to developmental biology, cancer research, and regenerative medicine.

GO:1901342, regulation of vasculature development, is defined as any process that modulates the frequency, rate or extent of vasculature development. In other words, it includes all molecular, cellular, and systemic mechanisms that either promote or inhibit the formation, growth, and remodeling of blood vessels. This regulation can occur at transcriptional, post-transcriptional, and signaling levels and is essential for normal organ development and tissue homeostasis [1, 2, 6].

Understanding the regulation of vasculature development is critical because blood vessels supply oxygen and nutrients to virtually every tissue, and their improper formation or function contributes to a wide range of human diseases. From tumor angiogenesis to ischemic disorders and developmental defects, the regulatory mechanisms that control vascular growth are prime targets for therapeutic intervention [3, 4, 7].

The following genes and proteins have been experimentally implicated in the regulation of vasculature development across various model systems.

Regulation of vasculature development is controlled by a complex interplay of signaling pathways, transcription factors, and metabolic cues. Notch signaling acts as a key angiocrine regulator in tumor development, modulating endothelial cell behavior and perivascular cell recruitment. In the lung, vascular development and regeneration are regulated by reciprocal signaling between endothelial and epithelial cells, involving factors such as VEGF and TGF-beta. Metabolic enzymes like pantothenate kinase 2 influence vascular development, linking coenzyme A synthesis to vascular patterning. Additionally, ribosomal stress pathways, as shown by rps20 deficiency, can impair hindbrain vascular development, indicating that protein synthesis capacity is a regulatory node. Hormonal and local factors regulate the ovarian follicular vasculature, which undergoes cyclic changes. In the kidney, renal arteriole development is regulated by hemodynamic forces and paracrine signals.

Dysregulated vasculature development is a hallmark of cancer, where tumors stimulate new blood vessel formation to support growth and metastasis. Notch signaling functions as an angiocrine regulator of tumor development, and its perturbation can alter tumor vascularization. Targeting regulatory pathways of vasculature development is a major therapeutic strategy in oncology.

Abnormal regulation of vasculature development can lead to congenital vascular defects. For example, reduced expression of pantothenate kinase 2 in zebrafish embryos causes abnormal vasculature development, linking metabolic gene mutations to vascular phenotypes. Similarly, rps20 deficiency impairs hindbrain vascular development, suggesting a role for ribosomal proteins in developmental vascular disorders.

The development of ocular vasculature is tightly regulated, and its disruption can cause vision-threatening conditions such as retinopathy of prematurity and diabetic retinopathy. Zebrafish studies have elucidated the origins and development of ocular vasculature, providing a model to study these diseases.

Proper regulation of renal arteriole development is essential for kidney function and blood pressure control. In the ovary, the follicular vasculature is dynamically regulated, and its dysregulation can affect fertility and contribute to ovarian pathologies.

RNA sequencing of endothelial cells or whole organs during vascular development can identify genes and pathways differentially expressed. This approach has been used to uncover transcriptional programs regulating pulmonary vasculature development and to identify Notch-dependent genes in tumor angiogenesis.

Confocal and light-sheet microscopy in zebrafish allow real-time visualization of vascular development. Studies on hindbrain vascular development and ocular vasculature have utilized transgenic fluorescent reporters to track endothelial cells [2, 8].

CRISPR-Cas9 knockout, morpholino knockdown, and transgenic overexpression are used to test gene function. For example, rps20 knockdown in zebrafish revealed its role in hindbrain vascular development, and pank2 knockdown caused abnormal vasculature.

Western blotting, immunoprecipitation, and reporter assays can measure activation of signaling pathways such as Notch and VEGF. These methods have been applied to study Notch signaling in angiocrine regulation and VEGF signaling in ovarian vasculature.

Researchers studying regulation of vasculature development-related genes often need to determine whether a candidate gene is causally involved in vascular phenotypes. EDITGENE provides a comprehensive suite of CRISPR-based services to enable precise genetic manipulation in endothelial cells and animal models, accelerating the translation of genomic findings into functional insights.

Regulation of vasculature development (GO:1901342) is a fundamental biological process that integrates signaling, transcriptional, and metabolic inputs to shape the vascular system. Its dysregulation contributes to cancer, developmental disorders, and ocular and renal diseases. Understanding the genes and mechanisms involved provides opportunities for therapeutic intervention. EDITGENE offers advanced CRISPR services to functionally dissect these regulators, empowering researchers to translate genomic discoveries into biological insights.